Laura F. Alconcher
Hospital Interzonal General Dr. José Penna, Lainez 2403, PC 8000
Bahia Blanca, B, Argentina
Bahia Blanca, B, Argentina
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Genetically negative aHUS and the possibility of undetected STEC-HUS.
Journal: Pediatric nephrology (Berlin, Germany)
Published: June 12, 2026
Impact of early volume expansion on severe long-term kidney sequelae in children with Shiga toxin-producing Escherichia coli hemolytic uremic syndrome.
Journal: Pediatric nephrology (Berlin, Germany)
Published: May 03, 2026
Non-Diarrheal STEC-HUS in Children: Expanding the Clinical and Diagnostic Spectrum.
Journal: Pediatrics international : official journal of the Japan Pediatric Society
Published: April 22, 2026
Beyond the kidney: prevalence of extrarenal complications and their long-term sequelae in Shiga toxin-producing Escherichia coli hemolytic uremic syndrome.
Journal: Pediatric nephrology (Berlin, Germany)
Published: January 09, 2026
A pediatric case of C3 glomerulonephritis initially misclassified as IgA nephropathy with a favorable response to C3-targeted therapy.
Journal: Pediatric nephrology (Berlin, Germany)
Published: December 03, 2025
Secondary thrombotic microangiopathy in children-a central role for the glycocalyx.
Journal: Kidney international
Published: October 03, 2025
Blood in urine: an early and constant finding for STEC-HUS diagnosis.
Journal: Pediatric nephrology (Berlin, Germany)
Published: September 20, 2025
Improving hemolytic uremic syndrome diagnosis in children: the role of serology for Shiga toxin-producing Escherichia coli detection.
Journal: Pediatric nephrology (Berlin, Germany)
Published: July 30, 2025
Predictors of spontaneous resolution of prenatally detected primary non-refluxing megaureter: A retrospective cohort study.
Journal: Archivos argentinos de pediatria
Published: May 20, 2025
Response to Dr Ahmed and Dr Farooqi: Eculizumab versus plasma exchange for pediatric anti-FH antibody-associated atypical hemolytic uremic syndrome.
Journal: Pediatric nephrology (Berlin, Germany)
Published: October 31, 2024
Open-label, controlled, phase 2 clinical trial assessing the safety, efficacy, and pharmacokinetics of INM004 in pediatric patients with Shiga toxin-producing Escherichia coli-associated hemolytic uremic syndrome.
Journal: Pediatric nephrology (Berlin, Germany)
Published: July 16, 2024
Last Updated: 09/26/2026